Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Xeris Pharmaceuticals Inc (NQ: XERS )

4.198 USD -0.742 (-15.02%)
Streaming Delayed Price Updated: 11:28 AM EST, Mar 5, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Xeris Pharmaceuticals Inc

< Previous 1 2 3 4 5 6 7 8 9 Next >
Noteworthy Tuesday Option Activity: XERS, PS, FICO
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Xeris Pharmaceuticals Inc (XERS), where a total of 10,908 contracts have traded so far,... 
Tags Stocks
From Market News Video
Xeris Pharmaceuticals: Q3 Earnings Insights
Shares of Xeris Pharmaceuticals (NASDAQ:XERS) moved higher by 4.6% in pre-market trading after the company reported Q3 ... 
Tags News XERS Market News
From Benzinga
Xeris Pharmaceuticals Reports Third Quarter 2020 Financial Results and Corporate Highlights
Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use (RTU) injectable and... 
From Business Wire News Releases
Earnings Scheduled For November 9, 2020
Companies Reporting Before The Bell • General Finance (NASDAQ:GFN) is projected to report quarterly earnings at $0.03 ... 
Tags Earnings WVE STXS
From Benzinga
The Week Ahead In Biotech: Supernus, Sanofi Await FDA Decisions
Biotech stocks turned around with the broader market in the week ended Nov. 6, as investors warmed to the idea of a split Congress and a ... 
Tags ARNA EYEN IMAB
From Benzinga
Xeris Pharmaceuticals to Announce Third Quarter 2020 Financial Results and Host Conference Call and Webcast on November 9, 2020
Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use injectable and infusible... 
From Business Wire News Releases
Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug... 
From Business Wire News Releases
The Daily Biotech Pulse: Prothena Progress In Parkinson's Disease Pipeline, Fast Track For Xeris, Biogen Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags BIIB APTX HALO
From Benzinga
40 Stocks Moving in Wednesday's Pre-Market Session
Gainers Astrotech Corporation (NASDAQ: ASTC) rose 217.5% to $5.27 in pre-market trading after the company announced partnership ... 
Tags CTIB ITRM JFU
From Benzinga
16 Stocks Moving In Tuesday's After-Hours Session
Gainers Astrotech (NASDAQ: ASTC) shares are trading higher after the company announced it partnered with TheCleveland Clinic ... 
Tags NAVI PE PRTA
From Benzinga
12 Healthcare Stocks Moving In Tuesday's After-Market Session
Gainers Xeris Pharmaceuticals (NASDAQ:XERS) stock moved upwards by 10.47% to $5.8 during Tuesday's after-market session. Xeris ... 
Tags Movers After/Hours Center REPL
From Benzinga
Xeris Pharmaceuticals Granted Fast Track Designation by the FDA for Its Novel Concentrated Diazepam Formulation (XP-0863) For Injection
Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug... 
From Business Wire News Releases
First Week of XERS December 18th Options Trading
Investors in Xeris Pharmaceuticals Inc (XERS) saw new options become available this week, for the December 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the... 
Tags Stocks
From Market News Video
Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug... 
From Business Wire News Releases
Thinking about buying stock in Under Armour, Cassava Sciences, Norwegian Cruise Line, Xeris Pharmaceuticals, or Delta Air Lines?
InvestorsObserver issues critical PriceWatch Alerts for UAA, SAVA, NCLH, XERS, and DAL. 
From PR Newswire
First Week of November 20th Options Trading For Xeris Pharmaceuticals (XERS)
Investors in Xeris Pharmaceuticals Inc (XERS) saw new options become available this week, for the November 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the... 
Tags Stocks
From Market News Video
24 Stocks Moving in Tuesday's Pre-Market Session
Gainers DAVIDsTEA Inc. (NASDAQ: DTEA) shares rose 62.6% to $1.41 in pre-market trading after the company reported a narrower Q2 ... 
Tags News VRM BXC
From Benzinga
Thinking about buying stock in Marinus Pharmaceuticals, Fiat Chrysler, Lithium Americas, Xeris Pharmaceuticals, or Nokia?
InvestorsObserver issues critical PriceWatch Alerts for MRNS, FCAU, LAC, XERS, and NOK. 
From PR Newswire
Thinking about buying stock in Rockwell Medical, Spotify, Xeris Pharmaceuticals, Blink Charging, or Nio Inc?
InvestorsObserver issues critical PriceWatch Alerts for RMTI, SPOT, XERS, BLNK, and NIO. 
From PR Newswire
Xeris Pharmaceuticals to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug... 
From Business Wire News Releases
64 Biggest Movers From Friday
Gainers PolyMet Mining Corp. (NYSE: PLM) shares jumped 63.6% to close at $4.40 on Friday after a Ramsey County District Court ... 
Tags PLM OMEX IEA
From Benzinga
55 Stocks Moving In Friday's Mid-Day Session
Gainers Shiloh Industries, Inc. (NASDAQ: SHLO) climbed 46.3% to $0.8629. Shiloh Industries shares jumped 100% on Thursday after ... 
Tags HOV LMPX Mid/Day Movers
From Benzinga
3 Penny Stocks To Buy According to These Analysts
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Epicenter Penny Stocks To Watch For September 2020
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug... 
From Business Wire News Releases
3 Penny Stocks To Watch As Health Care Sector Surges
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
The Daily Biotech Pulse: Pfizer-BioNTech Vaccine Data, Sorrento To Buy R&D Partner, Kymera IPO
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 20) 10X Genomics Inc (NASDAQ: TXG) Avenue Therapeutics ... 
Tags FBIO Top Stories ENTX
From Benzinga
34 Stocks Moving in Friday's Pre-Market Session
Gainers EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) shares rose 94.8% to $1.12 in pre-market trading. Eyepoint Pharmaceuticals ... 
Tags ENDP AESE KEYS
From Benzinga
Xeris Pharmaceuticals Appoints John Shannon President and Chief Operating Officer
Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use (RTU) injectable and... 
From Business Wire News Releases
XERS Makes Bullish Cross Above Critical Moving Average
In trading on Thursday, shares of Xeris Pharmaceuticals Inc (XERS) crossed above their 200 day moving average of $4.62, changing hands as high as $4.98 per share. Xeris Pharmaceuticals Inc shares are... 
Tags Stocks
From Market News Video
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.